Safety and efficacy of early initiation of sodium-glucose cotransporter-2 inhibitors after an acute coronary syndrome event: a meta-analysis of randomized controlled trials

Eur Heart J Cardiovasc Pharmacother. 2024 Nov 6;10(7):646-648. doi: 10.1093/ehjcvp/pvae047.

Renzo Laborante¹, Gianluigi Savarese^{2

3}, Giuseppe Patti^{4

5}, Domenico D'Amario^{4

5}

¹ Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy.
² Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm 17176, Sweden.
³ Heart and Vascular and Neurology Theme, Karolinska University Hospital, Stockholm 17176, Sweden.
⁴ Department of Translational Medicine, Università del Piemonte Orientale, Novara 28100, Italy.
⁵ Division of Cardiology, AOU Maggiore della Carità, Novara 28100, Italy.

No abstract available

Grants and funding